Funding, News and Announcements
» Go to news mainFunding to develop and manufacture vaccine technology for use against 2019‑nCoV
Posted by Jaq-Lin Larder on
February 10, 2020
in
Research Funding
CEPI has opened a call for proposals to rapidly develop and manufacture a proven vaccine approach that can be used against 2019-nCoV. This call aims to complement CEPI’s 2019-nCoV vaccine candidate portfolio.
The deadline for applications is Friday 14 Feb 2020, 15:00 CET (12:00 AST).
Applicants should have large manufacturing capabilities for vaccine candidates against 2019-nCoV. In addition, the organisation must be willing to transfer their vaccine platform to a global network of large-scale manufacturing.
Deadlines
Internal: February 12, 2020 at 4:30 pm. Contact shelley.brown@dal.ca.
Funder: February 14, 2020 at 12:00 pm AST
Recent News
- Canada Foundation for Innovation
- Council of Atlantic Academic Libraries
- CIMVHR True Patriot Love Research Initiative
- NSERC information session
- Dalhousie AI Symposium
- CFI Innovation Fund 2025
- Peer Review for CIHR Project Grant Fall 2024 Competition
- Congressionally Directed Medical Research Programs